| | 4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-|BTRX-335140 基本信息 更多信息 |
| 中文名稱: | BTRX-335140 | | 中文同義詞: | 化合物BTRX-335140;1-[6-乙基-8-氟-4-甲基-3-(3-甲基-1,2,4-噁二唑-5-基)-2-喹啉基]-N-(四氫-2H-吡喃-4-基)哌啶-4-胺;1-(6-乙基-8-氟-4-甲基-3-(3-甲基-1,2,4-惡二唑-5-基)喹啉-2-基)-N-(四氫-2H-吡喃-4-基)哌啶-4-胺;納瓦卡普蘭特 | | 英文名稱: | 4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)- | | 英文同義詞: | 4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-;BTRX-335140;CNS,BTRX-335140,CYM53093,U69593,Inhibitor,U2OS,Opioid Receptor,inhibit,BTRX335140,neurobehavioral disorder,CYM 53093,oral,BTRX 335140;1-[6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolyl]-N-(tetrahydro-2H-pyran-4-yl)piperidin-4-amine;1-(6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)piperidin-4-amine;CYM-53093;Navacaprant;1-[6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-4-piperidinamine (ACI) | | CAS號: | 2244614-14-8 | | 分子式: | C25H32FN5O2 | | 分子量: | 453.55 | | EINECS號: | | ![4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-|BTRX-335140](/CAS/20200119/GIF/2244614-14-8.gif) |
|
| 按國家瀏覽4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-國外供應商 |
中國供應商 |
|
4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)- 推薦供應商 |
|
|
建議您優(yōu)先選擇企業(yè)會員,我們對企業(yè)會員產品有嚴格審核。 |
|
1
|